Top 100 Molecular Diagnostics Manufacturers Examined by Research Facts in In-demand Report Published at MarketPublishers.com
24 Oct 2016 • by Natalie Aster
LONDON – Currently, there are many producers of in-vitro diagnostic (IVD) instruments, accessories and reagents. These firms have the experience, necessary know-how and reliable resources that enable them to develop, make and market novel products that compete favourably in global markets.
Belgium-based company, Biocartis Group NV, is developing and marketing a fast-paced growing test menu addressing major unmet clinical needs in infectious and oncology diseases, the biggest and most rapidly expanding segments of the USD 5 billion MDx marketplace. The company’s revenue stood at USD 16.7 million as of 2015.
HiberGene Diagnostics, headquartered in Dublin, is engaged in developing, making and marketing molecular diagnostic tests for human contagious diseases, utilising LAMP technology. In July 2016, the firm introduced its HG Group B Streptococcus (GBS) test allowing for accurate and fast diagnosis of the presence of group B streptococcus (GBS) in newborn children and pregnant women. In November 2015 the company introduced its HG Meningococcal test and mulls over releasing onward tests for Clostridium difficile and Norovirus.
In-demand research report “The Top 100 Manufacturers Of Molecular Diagnostics Worldwide” drawn up by Research Facts identifies and profiles the top 100 companies specialising in molecular diagnostics. For each company examined, the report provides Company contact details, such as address, phone and fax numbers, e-mail and website addresses; sheds light on key decision makers within the reviewed company – from CEO and main board to leading senior executives; touches upon such aspects as company review, product portfolio, clinical specialties and/or diseases, revenue, ownership, location status, the number of employees, etc.
The report is an indispensible reference tool for IVD associations.
More reports by the publisher can be found at Research Facts page.